Global Clinical Quality Conference 2021 has ended
avatar for David Fryrear

David Fryrear

Executive Vice President, Head of Quality Assurance
David Fryrear, M.S., is Executive Vice President and Head of the Quality Assurance for Astellas and has responsibility for providing the global vision, leadership and strategic direction for Quality Assurance, from the earliest stages of research, through clinical development, and all the way through to commercialization and beyond.

Fryrear is a senior business leader with more than 30 years of experience in the pharmaceutical industry. He has a proven track record in developing and leading global teams to deliver proactive and comprehensive quality strategies to enable excellence and support for pipeline development.

David joined Astellas in 2019 as Division Head of Clinical and Research Quality Assurance (CRQA), leading the strategic direction of CRQA in evolving the organization’s model of enhancing agility and effectiveness.
Prior to Astellas, David has held a number of senior positions leading quality along the continuum of development. He served as the Senior Director for Research & Development Quality Assurance at Abbvie, where he led a global staff of Clinical, Pharmacovigilance and Quality Knowledge Management QA professionals and was previously the Director of Safety, Efficacy & Customer Information Quality Systems at Eli Lilly and Company.

David earned his M.S. at Butler University College of Pharmacy and Health Sciences, Indianapolis where he Majored in Pharmaceutics and was the recipient of the Eli Lilly and Company Outstanding Graduate Seminar Award.

As a champion of excellence in clinical and research quality assurance activity and risk-based approaches, and an expert in the evolving regulatory and compliance landscape, David has delivered multiple publications and presentations on Clinical and Pharmacovigilance Quality and Quality Risk Management.

My Speakers Sessions

Wednesday, April 7

10:15am EDT

Thursday, April 8

8:30am EDT

8:45am EDT